Investor Centre

Pharmaxis Ltd (Pharmaxis) requests an immediate trading halt of its securities pending an announcement by the Company concerning the release by the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom of their Final Appraisal Determination for Bronchitol® (mannitol dry powder for inhalation) which is expected to be made by NICE during the course of today.